Get the Stockscreener App
1.66
1.78%
-0.03
Pre-market:
1.71
0.05
+3.01%
Nautilus Biotechnology Inc stock is traded at $1.66, with a volume of 436.29K.
It is down -1.78% in the last 24 hours and down -17.00% over the past month.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
See More
Previous Close:
$1.69
Open:
$1.71
24h Volume:
436.29K
Relative Volume:
0.66
Market Cap:
$210.95M
Revenue:
-
Net Income/Loss:
$-57.09M
P/E Ratio:
-3.675
EPS:
-0.4517
Net Cash Flow:
$-51.43M
1W Performance:
-1.78%
1M Performance:
-17.00%
6M Performance:
-25.56%
1Y Performance:
+119.03%
1-Day Range:
$1.65
$1.74
1-Week Range:
$1.65
$1.79
52-Week Range:
$0.62
$4.3101
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Name
Nautilus Biotechnology Inc
Sector
Industry
Phone
206-333-2001
Address
2701 EASTLAKE AVE EAST, SEATTLE
Compare NAUT vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
1.66 | 210.95M | 0 | -57.09M | -51.43M | -0.4517 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 37.17B | 4.29B | 577.22M | 641.34M | 4.2086 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-05-24 | Downgrade | Goldman | Neutral → Sell |
| Jun-27-24 | Initiated | Guggenheim | Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-06-22 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-02-21 | Initiated | Cowen | Outperform |
| Aug-04-21 | Initiated | Goldman | Neutral |
| Jul-13-21 | Initiated | Jefferies | Buy |
View All
Nautilus Biotechnology Inc Stock (NAUT) Latest News
Price to earnings forward of Nautilus Biotechnology, Inc. – NASDAQ:NAUT - TradingView
Nautilus Biotechnology Inc (NAUT) Cash Flow - TradingKey
Nautilus Biotechnology Inc (NAUT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NAUT|Nautilus Biotechnology Inc|Price:1.690|Chg%:-0.080 - TradingKey
Nautilus Biotechnology Inc (NAUT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nautilus Biotechnology Inc (NAUT) Valuation: PE, PB & Fair Value Analysis - TradingKey
NAUT|Nautilus Biotechnology Inc|Price:1.670|Chg%:-0.020 - TradingKey
Nautilus Biotechnology Inc (NAUT) Institutional Confidence - TradingKey
TradingKey - TradingKey
Nautilus Biotechnology Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
Nautilus Biotechnology invites project proposals for Tau Proteoforms Assay grant program - Traders Union
Nautilus Biotechnology (NAUT) Surges 6.1%: Breakout Above Key Support Zone Triggers Buying MomentumCTA Positioning - dars.gov.et
Nautilus Biotechnology And 2 Promising Penny Stocks To Consider - Sahm
Nautilus Biotechnology (NAUT) Holds Steady Near Support as Biotech Sector Faces Mixed SentimentCash Secured Put - dars.gov.et
Nautilus Biotechnology to present single molecule proteomics webinar on Voyager Platform - Traders Union
Nautilus Biotechnology to announce Q2 2026 results on July 28 - scanx.trade
Nautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026 - Investing News Network
Nautilus Biotechnology sets July 28 call on Q2 results - Stock Titan
Enterprise value to EBIT forward of Nautilus Biotechnology, Inc. – NASDAQ:NAUT - TradingView
Price to book forward of Nautilus Biotechnology, Inc. – NASDAQ:NAUT - TradingView
Price to sales forward of Nautilus Biotechnology, Inc. – NASDAQ:NAUT - TradingView
Enterprise value to revenue forward of Nautilus Biotechnology, Inc. – NASDAQ:NAUT - TradingView
Nautilus Biotechnology event to reveal new Iterative Mapping method for scientific clarity - Traders Union
Nautilus Biotechnology Appoints Amber Faust Vice Pres of Global Sales >NAUT - Moomoo
Nautilus Biotechnology (NAUT) Faces Pressure as Shares Decline Nearly 6%Head and Shoulders - dars.gov.et
Nautilus Biotechnology (NAUT) Slides 1.6%, Hovering Near Support LevelsLow Vol ETF - DonanımHaber
Form 13D/A Nautilus Biotechnology For: 30 June By Investing.com - Investing.com Nigeria
Andreessen Horowitz trims Nautilus (NAUT) stake in June 2026 block trade - Stock Titan
Nautilus Biotechnology, Inc.(NasdaqCM:NAUT) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell 2500 Growth Benchmark - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell 2000 Index - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell 2000 Value Benchmark - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM:NAUT) added to Russell Microcap Value Benchmark Index - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM:NAUT) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell 2000 Growth Benchmark - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell 3000E Growth Benchmark - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell Microcap Index - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell 2500 Index - marketscreener.com
Nautilus Biotechnology, Inc.(NasdaqCM: NAUT) added to Russell 2500 Value Benchmark - marketscreener.com
Nautilus Biotechnology Inc (NAUT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Nautilus Biotechnolgy, Inc. Actuals & Estimates (NASDAQ:NAUT) - TradingView
NAUTILUS BIOTECHNOLOGY INC (NAUT) Stock Chart - ChartMill
NAUT Forecast — Price Target — Prediction for 2027 - TradingView
Nautilus Biotechnology (NAUT) Holds Near Resistance After Moderate Upward MoveALMA Signal - dars.gov.et
[Form 4] Nautilus Biotechnology, Inc. Insider Trading Activity - Stock Titan
Director at Nautilus (NAUT) granted 45,000 stock options vesting monthly - Stock Titan
Nautilus Biotechnology (NAUT) grants 45,000 stock options to director - Stock Titan
NAUTNautilus Biotechnology Inc Earnings - Finviz
Nautilus Biotech stockholders approve directors and governance items - TipRanks
Nautilus Biotechnology (NAUT) investors approve directors, auditor and annual Say on Pay - Stock Titan
NAUT News | NAUTILUS BIOTECHNOLOGY INC (NASDAQ:NAUT) - ChartMill
Nautilus Biotechnology Inc Stock (NAUT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):